NDatalyzeNDATF Current Ratio is 19.31 as of Feb. 2026, which is 4% above its 10-year median of 18.52. Among 680 Healthcare Providers & Services companies, NDatalyze ranks better than 98.38% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. NDatalyze's current ratio for the quarter that ended in Feb. 2026 was 19.31.
NDatalyze has a current ratio of 19.31. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for NDatalyze's Current Ratio or its related term are showing as below:
NDATF'
s Current Ratio Range Over the Past 10 Years
Min: 2.91 Med: 18.52 Max: 22.47
Current: 19
During the past 8 years, NDatalyze's highest Current Ratio was 22.47. The lowest was 2.91. And the median was 18.52.
NDATF's Current Ratio is ranked better than 98.38% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs NDATF: 19.00
NDatalyze (OTCPK:NDATF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
NDatalyze Current Ratio Related Terms
NDatalyze Current Ratio Historical Data
* Premium members only.
The historical data trend for NDatalyze's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NDATF vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, NDatalyze's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NDatalyze Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's Current Ratio distribution charts can be found below:
* The bar in red indicates where NDatalyze's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NDatalyze (NDATF) has a Current Ratio of 19.31 as of Feb. 2026. This is near median its historical median of 18.52. Over the past decade, NDatalyze's Current Ratio has ranged from 2.91 to 22.47. According to the industry distribution chart, NDatalyze ranks #11 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 1.6%.
Is NDatalyze's Current Ratio too high?
NDatalyze's current Current Ratio of 19.31 is near median its 10-year median of 18.52. Over the past 10 years, this metric has ranged from a low of 2.91 to a high of 22.47. The Healthcare Providers & Services industry median Current Ratio is 1.47. NDatalyze's value of 19.31 is 1213.6% above this industry median. Based on the distribution chart, NDatalyze ranks #11 out of 680 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does NDatalyze's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NDatalyze ranks #11 out of 680 companies for Current Ratio. This places NDatalyze in the top 2% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. NDatalyze's value of 19.31 is 1213.6% above this benchmark. Historically, NDatalyze's own Current Ratio has ranged from 2.91 to 22.47 over the past decade. While the company's 10-year median is 18.52 vs. the industry median of 1.47, NDatalyze has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NDatalyze's current Current Ratio of 19.31 is 1213.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NDatalyze's current Current Ratio is 19.31, which is near median its own 10-year median of 18.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NDatalyze stock overvalued right now?
Based on GuruFocus' analysis, NDatalyze (NDATF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current Current Ratio is 19.31, which is near median its 10-year median of 18.52 and 1213.6% above the Healthcare Providers & Services industry median of 1.47. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For NDatalyze (NDATF), the current Current Ratio is 19.31 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NDATF has been successfully added to your 